Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers.
作者信息
Wang Ralph C, Murphy Charles E, Kornblith Aaron E, Kurtz Theodore, Kohn Michael A
机构信息
Department of Emergency Medicine, University of California, San Francisco, CA.
Department of Emergency Medicine, Department of Pediatrics, University of California, San Francisco, CA.
出版信息
Ann Emerg Med. 2021 May;77(5):556-557. doi: 10.1016/j.annemergmed.2021.01.010. Epub 2021 Jan 11.
Abstract
摘要
相似文献
1
Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers.急诊医学医护人员中新冠病毒抗体的流行情况。
Ann Emerg Med. 2021 May;77(5):556-557. doi: 10.1016/j.annemergmed.2021.01.010. Epub 2021 Jan 11.
2
Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.奥地利林茨两家急症医院医护人员中新冠病毒2型抗体的流行情况。
Clin Chem Lab Med. 2021 Jan 11;59(6):e231-e234. doi: 10.1515/cclm-2020-1681. Print 2021 May 26.
3
Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.儿科医护人员中新冠病毒抗体的流行情况。
Int J Infect Dis. 2021 Apr;105:474-481. doi: 10.1016/j.ijid.2021.03.017. Epub 2021 Mar 12.
4
Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.2021 年 1 月至 3 月肯尼亚献血者全国血清学监测中 SARS-CoV-2 抗体的流行率。
JAMA. 2021 Oct 12;326(14):1436-1438. doi: 10.1001/jama.2021.15265.
5
SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India.印度喀拉拉邦一家大型大学医院医护人员体内的新冠病毒抗体
Clin Microbiol Infect. 2021 Mar;27(3):481-483. doi: 10.1016/j.cmi.2020.09.013. Epub 2020 Sep 16.
6
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.2020 年 8 月至 10 月印度本地治里 SARS-CoV-2 感染的流行率和时间趋势。
Emerg Infect Dis. 2021 Feb;27(2):666-669. doi: 10.3201/2702.204480.
7
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
8
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.2020 年 4 月伊朗吉兰省 SARS-CoV-2 的血清流行率。
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.
9
Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.伊朗德黑兰：大流行早期医护人员与普通人群抗 SARS-CoV-2 特异性抗体的流行率比较。
Iran J Immunol. 2021 Mar;18(1):82-92. doi: 10.22034/iji.2021.88168.1851.
10
Epidemiology and Clinical Characteristics of Emergency Department Patients with COVID-19 in a Rhode Island Healthcare System.罗德岛医疗系统急诊 COVID-19 患者的流行病学和临床特征。
R I Med J (2013). 2021 Jun 1;104(5):24-29.
引用本文的文献
1
COVID-19 Seroprevalence in ED Health Care Professionals Study: A Cross-Sectional Study.急诊科医护人员 COVID-19 血清流行率研究：一项横断面研究。
J Emerg Nurs. 2022 Jul;48(4):417-422. doi: 10.1016/j.jen.2022.04.003. Epub 2022 Apr 22.
2
COVID-19 Infection and Symptoms Among Emergency Medicine Residents and Fellows in an Urban Academic Hospital Setting: Cross-sectional Questionnaire Study.城市学术医院环境中急诊医学住院医师和研究员的新冠病毒感染及症状：横断面问卷调查研究
JMIRx Med. 2022 Jan 27;3(1):e29539. doi: 10.2196/29539. eCollection 2022 Jan-Mar.
3
SARS COV-2 anti-nucleocapsid and anti-spike antibodies in an emergency department healthcare worker cohort: September 2020 - April 2021.2020 年 9 月至 2021 年 4 月急诊科医护人员队列中 SARS-CoV-2 的核衣壳和刺突抗体。
Am J Emerg Med. 2022 Apr;54:81-86. doi: 10.1016/j.ajem.2022.01.055. Epub 2022 Feb 2.
本文引用的文献
1
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.2020 年 4 月至 6 月，13 家学术医疗中心多州医院网络中一线医护人员中 SARS-CoV-2 的血清阳性率。
MMWR Morb Mortal Wkly Rep. 2020 Sep 4;69(35):1221-1226. doi: 10.15585/mmwr.mm6935e2.
2
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.2020年3月23日至5月12日美国10个地点针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体的血清流行率
JAMA Intern Med. 2020 Jul 21. doi: 10.1001/jamainternmed.2020.4130.
3
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.田纳西州纳什维尔市医护人员照顾 COVID-19 患者首月期间 SARS-CoV-2 的血清流行率。
Clin Infect Dis. 2021 May 4;72(9):1645-1648. doi: 10.1093/cid/ciaa936.
4
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.中国 SARS-CoV-2 免疫球蛋白 M 和 G 抗体的血清流行率。
Nat Med. 2020 Aug;26(8):1193-1195. doi: 10.1038/s41591-020-0949-6. Epub 2020 Jun 5.
Zotero 插件